On the recordMay 8, 2019
There ought to be transparency--transparency on the rebates and, I think, transparency on how much is really spent on R&D.
Source
congress.govEditor's note · Context
Welch calls for transparency in pharmaceutical pricing and R&D spending.
Share
More from Peter Welch
Nov 5, 2025
What’s at stake here is the separation of powers. That’s been hijacked not by an emergency but by a presidential whim.
May 13, 2025
You've got a Health and Human Service Secretary in Robert Kennedy who is on a destructive rampage, tearing apart institutional structures that have been in place to help us with the science and research and delivery of healthcare in this…
Jul 6, 2026
This project will make one of the most traveled highways in our state safer and more reliable, from Pittsford to Brandon and beyond.
Jun 24, 2026
I’m proud to work across the aisle on this legislation to support investments into developing new, PFAS-free turnout gear that protects firefighters across the country.
Other voices in this conversation
